Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A single amino acid change in the vitamin D receptor can disrupt its function and lead to hair loss.

Specific mutations in a receptor cause facial abnormalities and hair loss.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Caribine from traditional Chinese medicine may help treat hair loss.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Procyanidin B2 and leucopelargonidin from Saraca asoca may help treat PCOS by balancing hormones.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The vitamin D receptor can affect gene activity even without its usual hormone in hair and skin.

Parsley contains compounds that might be good for treating hair loss.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Analog 23 is a promising compound for prostate cancer treatment.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Vitamin D receptor and hairless protein are essential for hair growth.